A medication to ease cannabis withdrawal symptoms
Treatments studied
Part of Mental health clinical trials.
This study tests whether a medication called PP-01 can help reduce cravings and uncomfortable symptoms when people stop using cannabis. If you're a heavy cannabis user who wants to quit and experiences withdrawal symptoms, this trial may help you manage the difficult transition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–55 years old and generally healthy
- You use cannabis heavily (at least 1.5 grams daily, multiple times per day, at least 6 days per week for at least 6 months)
- You have experienced cannabis withdrawal symptoms before and are motivated to quit
- You agree to stop all cannabis use after starting the study and stay in the clinic for the first 6 days
- You do not have schizophrenia, bipolar disorder, or other serious untreated mental health conditions
- You have no other active drug addictions (other than nicotine or caffeine) and will not drink alcohol during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two cannabis-based medicines, dronabinol and Epidiolex, can help ease withdrawal symptoms or cravings in people who have just started buprenorphine for opioid use disorder. It may be a good fit if you are early in treatment and still have symptoms or slip-ups.
This study tests whether varenicline (a medication used to help quit smoking) can help people reduce or stop cannabis use. You may be eligible if you are an adult with cannabis use disorder who uses cannabis frequently and do not have certain medical or psychiatric conditions.
This trial tests if adding a specific cannabis product to standard methadone treatment helps people with opioid use disorder. It's for adults over 25 who recently started methadone and have used cannabis before.
This study tests whether cannabis can help people with moderate to severe opioid use disorder manage withdrawal symptoms.
This study tests whether cannabis can help people with opioid withdrawal and reduce opioid use. You will stay in a research center and receive cannabis in a controlled setting while researchers monitor your symptoms.
This trial tests whether tirzepatide (a medication that affects appetite and metabolism) can help people reduce or stop cannabis use. It is for adults who want treatment for cannabis use disorder.
Hear when a new Cannabis Withdrawal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.